Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Modeling and targeting cell-extracellular matrix communication to revert tissue fibrosis

Project description

Mapping skin fibrosis in 3D

Skin fibrosis is the scarring of the skin by the formation of connective tissue. It is not only painful but also disfiguring, and currently no treatment for the condition exists. The ERC-funded FibroRevert project aims to find a solution. To that end, it will examine the environment around skin cells. It will do this through 3D bioprinting techniques and specially designed lab-made gels, which are used to recreate the complex structure of human skin in vitro. By building these three-dimensional models guided by patient samples, FibroRevert hopes to observe how cells behave within scarred tissue. This will help researchers uncover clues that could one day contribute to reversing skin fibrosis.

Objective

Skin fibrosis is a complex disorder characterized by the replacement of healthy tissue by pathological extracellular matrix (ECM). Despite its significant health burden, current treatments remain largely ineffective, leaving patients without efficient therapies. This gap is due to a limited understanding of how ECM cues and cells of the fibrotic niche co-evolve and interact over time to drive fibrosis. To address this, we will dissect how space- and time-dependent changes in ECM properties during fibrotic remodelling drive dysfunctional alterations in cell-matrix communication, thus promoting fibrosis progression. To tackle this, we propose a multidisciplinary approach merging patient samples, bioinspired hydrogels, human cells, 3D bioprinting, and high-content analysis of fibrosis at cellular, molecular and tissue levels. With this patient-centred approach, we will create a modular hydrogel library with tissue-specific and programmable properties to uncover the role of ECM cues in fibrosis. By harnessing these new insights, we will capitalize on bioprinting to create unique 3D models recreating the heterogeneity and cell dynamics in human skin fibrosis to unveil tractable targets for therapeutic purposes. Overall, this high-impact project addresses a major health challenge – identify drivers of fibrosis – leading to the development of innovative 3D models for discovering therapeutics that ultimately reverse fibrosis without disturbing tissue homeostasis.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-STG

See all projects funded under this call

Host institution

I3S - INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO
Net EU contribution
€ 1 499 747,00
Address
RUA ALFREDO ALLEN 208
4200-135 Porto
Portugal
Region
Continente Norte Área Metropolitana do Porto
Activity type
Research Organisations
Links
Total cost
€ 1 499 747,00

Beneficiaries (1)